Home - Carmat :Carmat

Carmat, pioneering solutions to revolutionize the healthcare industry

press release

March 6th 2023

The first U.S. clinical experience with Aeson® TAH published in the Annals of Thoracic Surgery Short Reports
press release

February 23rd 2023

CARMAT announces its 2022 annual results and confirms its 2023 objectives

Investing in Carmat means choosing an innovative company with a long-term vision and technology unrivalled worldwide

Stéphane Piat

Carmat CEO

Carmat

isin : FR0010907956

EPA: ALCAR - 01 janvier 00:00

0 €